Le Bouc Y - Search Results

1

Evaluation of plasma insulin-like growth factor binding protein-2 as a marker for adrenocortical tumors.

Boulle N, Baudin E, Gicquel C, Logié A, Bertherat J, Penfornis A, Bertagna X, Luton JP, Schlumberger M, Le Bouc Y. Boulle N, et al. Among authors: le bouc y. Eur J Endocrinol. 2001 Jan;144(1):29-36. doi: 10.1530/eje.0.1440029. Eur J Endocrinol. 2001. PMID: 11174834

2

Recent advances in the pathogenesis of adrenocortical tumours.

Gicquel C, Bertagna X, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. Eur J Endocrinol. 1995 Aug;133(2):133-44. doi: 10.1530/eje.0.1330133. Eur J Endocrinol. 1995. PMID: 7655635 Review. No abstract available.

3

Oncogenic mutations of alpha-Gi2 protein are not determinant for human adrenocortical tumourigenesis.

Gicquel C, Dib A, Bertagna X, Amselem S, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. Eur J Endocrinol. 1995 Aug;133(2):166-72. doi: 10.1530/eje.0.1330166. Eur J Endocrinol. 1995. PMID: 7655640

4

Clonal analysis of human adrenocortical carcinomas and secreting adenomas.

Gicquel C, Leblond-Francillard M, Bertagna X, Louvel A, Chapuis Y, Luton JP, Girard F, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. Clin Endocrinol (Oxf). 1994 Apr;40(4):465-77. doi: 10.1111/j.1365-2265.1994.tb02485.x. Clin Endocrinol (Oxf). 1994. PMID: 7910530

5

Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors.

Gicquel C, Bertagna X, Schneid H, Francillard-Leblond M, Luton JP, Girard F, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. J Clin Endocrinol Metab. 1994 Jun;78(6):1444-53. doi: 10.1210/jcem.78.6.7911125. J Clin Endocrinol Metab. 1994. PMID: 7911125

6

[Insulin-like growth factor II (IGF II) and adrenocortical tumorigenesis].

Gicquel C, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. Ann Endocrinol (Paris). 1995;56(6):617-8. Ann Endocrinol (Paris). 1995. PMID: 8787355 French. No abstract available.

7

Molecular markers for malignancy in adrenocortical tumors.

Gicquel C, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. Horm Res. 1997;47(4-6):269-72. doi: 10.1159/000185475. Horm Res. 1997. PMID: 9167963

8

Adrenocortical carcinoma.

Gicquel C, Baudin E, Lebouc Y, Schlumberger M. Gicquel C, et al. Ann Oncol. 1997 May;8(5):423-7. doi: 10.1023/a:1008257530919. Ann Oncol. 1997. PMID: 9233519 Free article. Review. No abstract available.

9

Structural and functional abnormalities at 11p15 are associated with the malignant phenotype in sporadic adrenocortical tumors: study on a series of 82 tumors.

Gicquel C, Raffin-Sanson ML, Gaston V, Bertagna X, Plouin PF, Schlumberger M, Louvel A, Luton JP, Le Bouc Y. Gicquel C, et al. Among authors: le bouc y. J Clin Endocrinol Metab. 1997 Aug;82(8):2559-65. doi: 10.1210/jcem.82.8.4170. J Clin Endocrinol Metab. 1997. PMID: 9253334

10

Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.

Boulle N, Logié A, Gicquel C, Perin L, Le Bouc Y. Boulle N, et al. Among authors: le bouc y. J Clin Endocrinol Metab. 1998 May;83(5):1713-20. doi: 10.1210/jcem.83.5.4816. J Clin Endocrinol Metab. 1998. PMID: 9589681

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters